Industry wary over government’s new pharma policyPost published:August 21, 2017Post category:Industry NewsThe current draft pharma policy may have a negative impact on growth and profitability of the industry due to continued emphasis on price control, say industry officials and analysts Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndian Oil and Odisha government settle tax dispute Next PostRosneft closes $13-billion Essar Oil acquisition deal You Might Also Like ABB to help Polish company enhance management of national power network February 15, 2018 Lanner introduces V3G and V3S vehicle gateway controllers May 30, 2018 Bank consolidation: 5 mergers from the past August 24, 2017